Immunotherapy for Brain Tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/article/10.1007/s11864-018-0576-3/fulltext.html
Reference110 articles.
1. •• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442 This report compiled by the American Cancer Society includes the most recent data on cancer incidence, mortality, and survival as well as estimations of the numbers of new cancer cases and deaths that will occur in the United States.
2. •• Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–41. https://doi.org/10.1038/nature14432 This article is the first to report the discovery of meningeal lymphatic vessels (or meningeal lymphatics), which are functional lymphatic vessels located parallel to the dural sinuses and meningeal arteries of the mammalian central nervous system. This is a significant finding in the field of neuroimmunology as it revolutionizes the traditional view of the brain being an immune-privileged entity.
3. Manglani M, McGavern DB. New advances in CNS immunity against viral infection. Curr Opin Virol. 2018;28:116–26. https://doi.org/10.1016/j.coviro.2017.12.003 .
4. Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol 2017b;18(10):1373–85. doi: https://doi.org/10.1016/S1470-2045(17)30517-X .
5. Inoges S, Tejada S, de Cerio AL, Gallego Perez-Larraya J, Espinos J, Idoate MA, et al. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients. J Transl Med. 2017;15(1):104. https://doi.org/10.1186/s12967-017-1202-z .
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunostimulatory nanoparticles delivering cytokines as a novel cancer nanoadjuvant to empower glioblastoma immunotherapy;Drug Delivery and Translational Research;2023-12-31
2. Self-adjuvant nanovaccine delivering cytokines as a novel platform to empower glioblastoma immunotherapy;2023-11-01
3. Photodynamic therapy and associated targeting methods for treatment of brain cancer;Frontiers in Pharmacology;2023-09-28
4. Glioblastoma cellular MAP4K1 facilitates tumor growth and disrupts T effector cell infiltration;Life Science Alliance;2023-09-21
5. Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy;Advanced Drug Delivery Reviews;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3